|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910964172203321 |
|
|
Autore |
Lucio Steven |
|
|
Titolo |
Biosimilars and Biologics : Implementation and Monitoring in a Health Care Setting |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Bethesda : , : American Society of Health-System Pharmacists, , 2018 |
|
©2018 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (192 pages) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Biosimilar Pharmaceuticals |
Drug Compounding |
Drug Monitoring |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di contenuto |
|
A new type of blockbuster : the growth of biologics -- Déjá vu or something new? : comparing the generics and biosimilars experiences -- Bugs and drugs, and yeast and mice, and Chinese hamsters -- The $250 billion pyramid : analytics in biosimilarity determination -- The global biosimilars experience -- The American biosimilar experience : red, white, and possibly interchangeable -- Biosimilar clinical trial requirements -- Immunogenicity and pharmacovigilance in the biosimilar era -- The patent dance and the exclusivity shuffle -- Defining biosimilar value and other impossible tasks -- Biosimilar formulary management strategies. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Among the most anticipated and discussed segments of the pharmaceutical market, biosimilars are finally beginning to exert a greater impact on practice. ASHP's Biosimilars & Biologics: Implementation and Monitoring in a Healthcare Setting is an authoritative, evidence-based resource that provides an in-depth perspective on all areas related to these innovative drugs. |
|
|
|
|
|
|
|